- £10.16m
- £8.56m
- £2.86m
REG - Angle PLC - Interim Results
AnnouncementREG - Angle PLC - Change of Adviser
AnnouncementREG - Angle PLC - Notice of Results
AnnouncementREG - Angle PLC - ANGLE announces collaboration with Myriad Genetics
AnnouncementRCS - Angle PLC - PARSORTIX ENABLES STUDY OF CANCER PROGRESSION
AnnouncementREG - Angle PLC - Result of 2025 Annual General Meeting
AnnouncementRCS - Angle PLC - EACR 2025: Data demonstrating DNA dual analysis
AnnouncementRCS - Angle PLC - EACR 2025: Innovation in AR expression profiling
AnnouncementRCS - Angle PLC - Novel discoveries into the biology of cancer
AnnouncementREG - Angle PLC - POSTING OF ANNUAL REPORT AND NOTICE OF AGM
AnnouncementREG - Angle PLC - Board Changes
AnnouncementREG - Angle PLC - Preliminary Results
AnnouncementREG - Angle PLC - Notice of Results
AnnouncementRCS - Angle PLC - RESULTS SUPPORTING ANGLE’S HER2 ASSAY PROGRAMME
AnnouncementREG - Angle PLC - Results of Eisai Phase 2 pilot study
AnnouncementREG - Angle PLC - Issue of LTIP Options and Share Options
AnnouncementRCS - Angle PLC - Novel findings using Parsortix
AnnouncementREG - Angle PLC - Analysis of CTC-DNA and ctDNA using Illumina assay
AnnouncementRCS - Angle PLC - Parsortix used in research paper from ETH Zurich
Announcement